Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

New-age vaccine adjuvants, their development, and future perspective
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 85
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 56
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
Bowen Lu, Jing Ming Lim, Boyue Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 36
Whole tumour cell-based vaccines: tuning the instruments to orchestrate an optimal antitumour immune response
Amarilis Pérez-Baños, María Alejandra Gleisner, Iván Flores, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 4, pp. 572-585
Closed Access | Times Cited: 27
Adjuvants for COVID-19 Vaccines
Javier Castrodeza, Iván Sanz-Muñoz, José Marı́a Eiros Bouza
Vaccines (2023) Vol. 11, Iss. 5, pp. 902-902
Open Access | Times Cited: 25
Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations
Sivakumar S. Moni, Siddig İbrahim Abdelwahab, Aamena Jabeen, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1704-1704
Open Access | Times Cited: 23
Research progress on emulsion vaccine adjuvants
Zhuanqing Huang, Hui Gong, Qi Sun, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24662-e24662
Open Access | Times Cited: 11
Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses
Wenjiao Fu, Mengyu Guo, Xuemei Zhou, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11200-11216
Closed Access | Times Cited: 10
NAVIGATING THE LANDSCAPE OF ADJUVANTS FOR SUBUNIT VACCINES: RECENT ADVANCES AND FUTURE PERSPECTIVES
Fredmoore L. Orosco, Llewelyn Espiritu
International Journal of Applied Pharmaceutics (2024), pp. 18-32
Open Access | Times Cited: 8
Vaccine adjuvants: current status, research and development, licensing, and future opportunities
Ying Cui, Megan Ho, Yongjie Hu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 17, pp. 4118-4137
Open Access | Times Cited: 8
Silver Nanoparticles in Therapeutics and Beyond: A Review of Mechanism Insights and Applications
Furkan Eker, Hatice Duman, Emir Akdaşçi, et al.
Nanomaterials (2024) Vol. 14, Iss. 20, pp. 1618-1618
Open Access | Times Cited: 8
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 21
Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine
Dan-Ping Zhao, Xiuhong Chen, Linyuan Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 234, pp. 123635-123635
Open Access | Times Cited: 19
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 18
Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases
Genada Sinani, Melike Sessevmez, Sevda Şenel
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1201-1201
Open Access | Times Cited: 7
Advancing PEDV Vaccination: Comparison between Inactivated and Flagellin N-Terminus-Adjuvanted Subunit Vaccines
Asad Murtaza, Nguyen-Thanh Hoa, Do Dieu-Huong, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 139-139
Open Access | Times Cited: 6
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 6
Vaccine process technology—A decade of progress
Barry C. Buckland, Gautam Sanyal, Todd Ranheim, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2604-2635
Open Access | Times Cited: 6
Hybrid polymeric systems for potential applications in vaccine delivery
Emma A. Kean, Oluwatoyin A. Adeleke
Elsevier eBooks (2025), pp. 395-451
Closed Access
PLGA co-loaded Salvia miltiorrhiza polysaccharide and Mn2+ as an adjuvant to induce potent immunity
Yixuan Zhu, Qi Zhao, Pengfei Gu, et al.
International Journal of Biological Macromolecules (2025), pp. 140050-140050
Closed Access
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development
Abdullah R. Alrasheed, Maaweya Awadalla, Hadeel Alnajran, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Colloidal Polyelectrolyte Complexes from Hyaluronic Acid: Preparation and Biomedical Applications
Huu Van Le, Didier Le Cerf
Small (2022) Vol. 18, Iss. 51
Open Access | Times Cited: 25
Microbial exopolysaccharides–β-glucans–as promising postbiotic candidates in vaccine adjuvants
Amin Abbasi, Tina Rahbar Saadat, Yalda Rahbar Saadat
International Journal of Biological Macromolecules (2022) Vol. 223, pp. 346-361
Closed Access | Times Cited: 25
From defense to offense: Modulating toll-like receptors to combat arbovirus infections
Rafidah Lani, Ilya Maisarah Thariq, Nuramira Syazreen Suhaimi, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits
Balasubramanian Arunachalam
Vaccines (2024) Vol. 12, Iss. 4, pp. 396-396
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top